Olaris, Inc.

MYOLARIS

MY OLARIS;Medical diagnostic solutions and platforms for medical and research purposes, namely, medical apparatus for testing the presence of biomarkers relevant for treatment responsiveness and drug efficacy;Providing medical and scientific testing information services for medical and scientific research purposes, namely, reporting test results and analysis of customers tests; computer aided biomarker discovery services for identifying potential biomarkers for use in researching disease, diagnosis of disease, drug compound safety, drug efficacy, treatment efficacy, therapy responsiveness, and drug side-effects; providing scientific analysis and informational reports based upon results of laboratory testing in the field of diagnostics and biomarkers; providing online computer databases featuring scientific information based on aggregated results of biomarker testing; application service provider (ASP) featuring software for providing access to multiple databases that contain aggregated results of biomarker testing; application service provider (ASP) featuring software for use in data management, data storage, data analysis, report generation, user identification, and membership identification, all in the fields of diagnostics and biomarkers; application service provider featuring application programming interface (API) software for connectivity with third party clinical health databases and platforms; software as a service (SAAS) services featuring software for providing access to multiple databases that contain aggregated results of biomarker testing software as a service (SAAS) services for use in data management, data storage, data analysis, report generation, user identification, and membership identification, all in the fields of diagnostics and biomarkers;

OLARIS

Providing an online resource center, namely, on-line non-downloadable articles and blogs in the field of healthcare, medicine, diagnostics, and biomarkers;Research and development in the field of identifying biomarkers for diagnostic, treatment, and drug and therapy efficacy purposes; research and development services in the field of diagnostic tools and tests for identifying biomarkers relevant to treatment and drug efficacy;

OLARIS

Medical diagnostic solutions and platforms for medical and research purposes, namely, medical apparatus for testing the presence of biomarkers relevant for treatment responsiveness and drug efficacy;Providing medical and scientific testing information services for medical and scientific research purposes, namely, reporting test results and analysis of customers tests; computer aided biomarker discovery services for identifying potential biomarkers for use in researching disease, diagnosis of disease, drug compound safety, drug efficacy, treatment efficacy, therapy responsiveness, and drug side-effects; Providing scientific analysis and informational reports based upon results of laboratory testing in the field of diagnostics and biomarkers; providing online computer databases featuring scientific information based on aggregated results of biomarker testing; application service provider (ASP) featuring software for providing access to multiple databases that contain aggregated results of biomarker testing; application service provider (ASP) featuring software for use in data management, data storage, data analysis, report generation, user identification, and membership identification, all in the fields of diagnostics and biomarkers;